NCT03066297View on ClinicalTrials.gov

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

1,018

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

February 15, 2027

Study Completion Date

February 15, 2027

Conditions
Stage IA Non-small Cell Lung Cancer
Interventions
PROCEDURE

Extent of pulmonary resection

Extent of pulmonary resection selected based on the institutional decision-making algorithm

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03066297 - Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter